Future cardiovascular risk interpreting the importance of increased blood pressure during pregnancy

Circulation

Volumn 127, Issue 6, 2013, Pages 668-669

  Intapad, Suttira ^a   Alexander, Barbara T ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; DYSLIPIDEMIA; EDITORIAL; HYPERTENSION; INSULIN RESISTANCE; MENOPAUSE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; KIDNEY DISEASES; PREGNANCY;

EID: 84873895196     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000677     Document Type: Editorial

References (17)

1. Mehta PK, Wenger NK. Coronary heart disease in women: battle is won, but the war remains. Minerva Med. 2007;98:459-478.
2. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156:918-930.
3. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122:579-584.
4. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol. 2009;114:961-970.
5. US Department of Health & Human Services, National Institutes of Health. NHLBI Workshop. Bridging Preeclampsia and Future Cardiovascular Disease. Executive Summary. http://www.nhlbi.nih.gov/meetings/workshops/bridging-pe.htm. Accessed January 8, 2013.
6. Mannisto T, Mendola P, Vaarasmaki M, Jarvelin M-R, Hartikainen A-L, Pouta A, Suvanto E. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681-690.
7. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243-1262.
8. Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3:120-127.
9. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. Washington, DC: The American College of Obstetricians and Gynecologists; 2002.
10. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391-403.
11. Yen TW, Payne B, Qu Z, Hutcheon JA, Lee T, Magee LA, Walters BN, von Dadelszen P. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study. J Obstet Gynaecol Can. 2011;33:803-809.
12. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002; 186:66-71.
13. Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009;24:147-158.
14. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125:911-919.
15. Hermes W, Van Kesteren F, De Groot CJ. Preeclampsia and cardiovascular risk. Minerva Ginecol. 2012;64:281-292.
16. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension. 2010;56:166-171.
17. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004;175:189-202.